Compare Sanofi SA (SNY) vs United Parcel Service Inc (UPS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Sanofi SA vs United Parcel Service Inc — how do they compare? Sanofi SA trades at $40.1 (market cap $96.81B), while United Parcel Service Inc trades at $94.4 (market cap $78.52B). The key difference: Sanofi SA is the larger of the two by market cap, and United Parcel Service Inc pays the higher dividend (7.11%). Which is the better fit depends on your goals — on Pluang, investors hold Sanofi SA for 94 Days and United Parcel Service Inc for 141 Days on average.
| SNY | UPS | |
|---|---|---|
Market Cap | $96.81B | $78.52B |
Volume | 2,081,815 | 5,159,366 |
Sector | Health | Industrials |
52-Week High | $52.34 | $120.00 |
52-Week Low | $39.51 | $82.87 |
Typical Hold Time | 94 Days | 141 Days |
Enterprise Value | $116.20B | $102.54B |
Dividend Yield | 6.02% | 7.11% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Sanofi (SNY) trades at $40.23, up 1.69% with recent earnings beats and strong revenue growth to $46.72B in 2025. The stock shows bearish technical signals but maintains solid fundamentals with a 22.2 P/E ratio and 72.77% gross margin. Recent expansion of the Regeneron immunology alliance represents significant strategic positioning for future growth beyond Dupixent.
While near-term technical pressure exists, SNY's fundamental strength and pipeline development provide long-term upside potential. Key risks include patent expiration concerns and competitive pressures in the pharmaceutical sector. Analyst consensus leans slightly positive with 44% buy ratings, though institutional sentiment remains cautious given technical indicators.
UPS trades at $92.28, down 0.89% on the day, with a bearish technical signal despite recent earnings beats. The company maintains solid fundamentals with a P/E of 17.15 and ROE of 29.66%, though revenue has declined from $100.3B in 2022 to $88.7B in 2025. Recent developments include the launch of UPS Secure Commerce and an exclusive TikTok Shop partnership.
The outlook is mixed: analyst consensus price target of $118.67 suggests 29% upside, but technical indicators and recent downgrades highlight near-term pressure. Key risks include fuel costs, domestic volume concerns, and Amazon competition, while the 7% dividend yield provides income support.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Sanofi SA
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Read more on SNY →About United Parcel Service Inc
United Parcel Service, Inc. (UPS) delivers packages and documents throughout the United States and in other countries and territories. The Company also provides global supply chain services and less-than-truckload transportation, primarily in the US UPS's business consists of integrated air and ground pick-up and delivery network
Read more on UPS →
